Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Gen
0:00 Intro0:25 Mazen’s lifelong commitment to furthering the field of precision medicine in liver di
0:00 Introduction0:25 Julia’s personal experience with ultra-rare diseases within her family10:25 Th
0:00 Introduction1:25 How Lord O’Shaughnessy became involved in scientific policy making and his pat
0:00 Introduction01:10 How growing up in Malawi planted the seeds for John’s career in medicine and
0:00 Introduction0:50 Holly’s background and career so far03:30 Complex decision-making and multiple
Summary: 0:00 Introduction01:01 How Leslie got into the field of synthetic biology and engineer
Summary: 0:00 Introduction0:50 Reflections from the 34th International Symposium on ALS/MND in
0:00 Introduction to Dr. Nicole Paulk, a pioneer in AAV research and the founder of Siren Biotechnol
0:00 Introduction01:00 Chris’ background and career to date02:10 What is the Enigma Project?04:48 Ho
Summary: 0:00 Introduction5:45 Lessons learned from 15 years at GSK: How has genetics and drug
Summary: 0:00 Introduction1:45 Wendy’s early career looking into the genetics of diabetes throu
0:00 Introduction4:23 Insights into clonal hematopoiesis from the pioneering Framingham Heart Study8
In the second instalment of our annual round-up episode, we welcome back Dr. Veera Rajagopal to cove
0:00 Introduction1:30 Veera’s personal highlights of 2023Publication in Nature Genetics: Rare coding
In this episode of The Genetics Podcast, we welcome Dr. Jason, founder and CEO of Empress Therapeuti
This week on The Genetics Podcast Patrick is joined by David Ochoa, Platform Coordinator at Open Tar
In this episode of The Genetics Podcast, we welcome Dr. James Field, founder and CEO of LabGenius. J
On this episode of The Genetics Podcast we welcome Dr. Barbara Kraatz Fortini, Associate Professor o
This week, we’re re-sharing one of our favorite episodes from the early days of The Genetics Podcast
In this episode of The Genetics Podcast, we're joined by Dimitar Tonev, an experienced drug developm
